Marijuana Research Today is a free monthly online journal that collates and summarizes the latest research about Marijuana, including details on benefits, cancer, effects, uses, addiction.

Volume 5 (2008), Issue 4 (April)

1. Exposure to the tsunami disaster, PTSD symptoms and increased substance use - an Internet based survey of male and female residents of Switzerland.
   BMC Public Health, 8: 92. [Abstract] [Full-text]
2. Effects of cannabidiol on schizophrenia-like symptoms in people who use cannabis.
   Br J Psychiatry, 192: 306-7. [Abstract] [Full-text]
3. Computerized screening for alcohol and drug use among adults seeking outpatient psychiatric services.
   Psychiatr Serv, 59(4): 441-4. [Abstract] [Full-text]
4. Excessive brain volume loss over time in cannabis-using first-episode schizophrenia patients.
   Am J Psychiatry, 165(4): 490-6. [Abstract] [Full-text]
5. Volumetric MRI study of brain in children with intrauterine exposure to cocaine, alcohol, tobacco, and marijuana.
   Pediatrics, 121(4): 741-50. [Abstract] [Full-text]
6. Relationship between physical disabilities or long-term health problems and health risk behaviors or conditions among US high school students.
   J Sch Health, 78(5): 252-7; quiz 298-9. [Abstract] [Full-text]
7. Cerebral glucose metabolism and D2/D3 receptor availability in young adults with cannabis dependence measured with positron emission tomography.
   Psychopharmacology (Berl), 197(4): 549-56. [Abstract] [Full-text]
8. Endocannabinoid functions controlling neuronal specification during brain development.
   Mol Cell Endocrinol. [Abstract] [Full-text]
9. Use of dronabinol for cannabis dependence: two case reports and review.
   Am J Addict, 17(2): 161-4. [Abstract] [Full-text]
10. The association between earlier marijuana use and subsequent academic achievement and health problems: a longitudinal study.
    Am J Addict, 17(2): 155-60. [Abstract] [Full-text]
11. Contextual Influences on Polydrug Use among Young, Low-Income Women: Effects of Neighborhood and Personal Networks.
    Am J Addict, 17(2): 135-44. [Abstract] [Full-text]
12. Predictors of cardiovascular response to methamphetamine administration in methamphetamine-dependent individuals.
    Am J Addict, 17(2): 103-10. [Abstract] [Full-text]
13. Defaulters from antiretroviral treatment in Jimma University Specialized Hospital, Southwest Ethiopia.
    Trop Med Int Health, 13(3): 328-33. [Abstract] [Full-text]
14. The relation between the use of psychoactive substances and the severity of the injury in a group of crash-involved drivers admitted to a regional trauma center.
    Traffic Inj Prev, 9(2): 105-8. [Abstract] [Full-text]
15. Determination of plasma and urine levels of Delta9-tetrahydrocannabinol and its main metabolite by liquid chromatography after solid-phase extraction.
    J Pharm Biomed Anal, 47(1): 156-63. [Abstract] [Full-text]
16. Cannabis use disrupts eyeblink conditioning: evidence for cannabinoid modulation of cerebellar-dependent learning.
    Neuropsychopharmacology, 33(6): 1432-40. [Abstract] [Full-text]
17. Concentrations of cocaine and its major metabolite benzoylecgonine in blood samples from apprehended drivers in Sweden.
    Forensic Sci Int, 177(2): 133-9. [Abstract] [Full-text]
18. Cannabis smoking and periodontal disease among young adults.
    Br Dent J, 204(7): 383. [Abstract] [Full-text]
19. Childhood sexual abuse, early cannabis use, and psychosis: testing an interaction model based on the National Comorbidity Survey.
    Schizophr Bull, 34(3): 580-5. [Abstract] [Full-text]
20. Swiss Psychiatrists Beliefs and Attitudes about Cannabis Risks in Psychiatric Patients: Ideologically Determined or Evidence-based?
    Community Ment Health J, 44(2): 86-96. [Abstract] [Full-text]
21. Drug Resistance Strategies and Substance Use among Adolescents in Monterrey, Mexico.
    J Prim Prev, 29(2): 167-92. [Abstract] [Full-text]
22. Estimating the costs of drug-related hospital separations in Australia.
    Aust N Z J Public Health, 32(2): 156-61. [Abstract] [Full-text]
23. Cannabis withdrawal predicts severity of cannabis involvement at 1-year follow-up among treated adolescents.
    Addiction, 103(5): 787-99. [Abstract] [Full-text]
24. The contribution of research to the development of a national cannabis policy in Australia.
    Addiction, 103(5): 712-20. [Abstract] [Full-text]
25. Alcohol, marijuana, and tobacco use patterns among youth in Canada.
    Cancer Causes Control, 19(4): 361-9. [Abstract] [Full-text]
26. Immigrant advantage? Substance use among Latin American immigrant and native-born youth in Spain.
    Ethn Health, 13(2): 149-70. [Abstract] [Full-text]
27. Understanding the association between adolescent marijuana use and later serious drug use: Gateway effect or developmental trajectory?
    Dev Psychopathol, 20(2): 615-32. [Abstract] [Full-text]
28. Managing neuropathic pain with Sativex: a review of its pros and cons.
    Expert Opin Pharmacother, 9(7): 1189-95. [Abstract] [Full-text]
29. The cannabinoid system and male reproductive functions.
    J Neuroendocrinol, 20: 90-3. [Abstract] [Full-text]
30. Interplay between endocannabinoids, steroids and cytokines in the control of human reproduction.
    J Neuroendocrinol, 20: 82-9. [Abstract] [Full-text]
31. Multiple roles for the endocannabinoid system during the earliest stages of life: pre- and postnatal development.
    J Neuroendocrinol, 20: 75-81. [Abstract] [Full-text]
32. Endogenous cannabinoids: structure and metabolism.
    J Neuroendocrinol, 20: 1-9. [Abstract] [Full-text]
33. Adolescent risk factors for adult alcohol use and abuse: stability and change of predictive value across early and middle adulthood.
    Addiction, 103: 84-99. [Abstract] [Full-text]
34. The NARCONON drug education curriculum for high school students: a non-randomized, controlled prevention trial.
    Subst Abuse Treat Prev Policy, 3: 8. [Abstract] [Full-text]
35. Conjoint developmental trajectories of young adult substance use.
    Alcohol Clin Exp Res, 32(5): 723-37. [Abstract] [Full-text]
36. Cannabinoid Ester Constituents from High-Potency Cannabis sativa.
    J Nat Prod, 71(4): 536-42. [Abstract] [Full-text]
37. Cannabinoid modulation of executive functions.
    Eur J Pharmacol, 585(2): 458-63. [Abstract] [Full-text]
38. Cannabis and the developing brain: insights from behavior.
    Eur J Pharmacol, 585(2): 441-52. [Abstract] [Full-text]
39. The influence of perceived risk to health and immigration-related characteristics on substance use among Latino and other immigrants.
    Am J Public Health, 98(5): 862-8. [Abstract] [Full-text]
40. Cognitive deficits in marijuana users: Effects on motivational enhancement therapy plus cognitive behavioral therapy treatment outcome.
    Drug Alcohol Depend, 95(3): 279-83. [Abstract] [Full-text]
41. The phytocannabinoid Delta(9)-tetrahydrocannabivarin modulates inhibitory neurotransmission in the cerebellum.
    Br J Pharmacol, 154(1): 204-15. [Abstract] [Full-text]
42. Smoking tobacco along with marijuana increases symptoms of cannabis dependence.
    Drug Alcohol Depend, 95(3): 199-208. [Abstract] [Full-text]
43. The endocannabinoid system in cancer-potential therapeutic target?
    Semin Cancer Biol, 18(3): 176-89. [Abstract] [Full-text]

© 2004-2011 Marijuana Research Today. All Rights Reserved.